Effectiveness of Human Recombinant Thrombomodulin for Septic Disseminated Intravascular Coagulation in Perioperative Care in Digestive Surgery-Reference-Cited by-同舟云学术

Effectiveness of Human Recombinant Thrombomodulin for Septic Disseminated Intravascular Coagulation in Perioperative Care in Digestive Surgery

Published:2014 Issue:12 Volume:47 Page:743-754
ISSN:0386-9768
Container-title:The Japanese Journal of Gastroenterological Surgery
language:en
Short-container-title:Jpn J Gastroenterol Surg, Nihon Shokaki Geka Gakkai zasshi

Author:

Sugase Takahito¹,Yamada Terumasa¹,Okuyama Masaki¹,Nagaoka Satoshi¹,Nakagawa Tomo¹,Kim Chiwan¹,Hiraoka Kazuya¹,Konishi Ken¹,Endo Shunjij¹,Nishijima Junichi¹

Affiliation:

1. Department of Gastroenterological Surgery, Higashiosaka City General Hospital

Publisher

The Japanese Journal of Gastroenterological Surgery

Subject

Gastroenterology,Surgery

Link

https://www.jstage.jst.go.jp/article/jjgs/47/12/47_2014.0075/_pdf

Reference22 articles.

1. 3. Disseminated Intravascular Coagulation Syndrome 2) Treatment Strategy

2. 3) Saito H, Maruyama I, Shimazaki S, Yamamoto Y, Aikawa N, Ohno R, et al. Efficacy and safety of recombinant human soluble thrombomodulin (ART-123) in disseminated intravascular coagulation: results of a phase III, randomized, double-blind clinical trial. J Thromb Haemost. 2007 Jan;5(1):31–41.

3. Effects of recombinant human soluble thrombomodulin and danaparoid sodium for sepsis-induced disseminated intravascular coagulation

4. Therapeutic effect of recombinant thrombomodulin on the hemostatic and inflammatory response in patients with septic DIC

5. 8) Yuksel M, Okajima K, Uchiba M, Horiuchi S, Okabe H. Activated protein C inhibits lipopolysaccharide-induced tumor necrosis factor-alpha production by inhibiting activation of both nuclear factor-kappa B and activator protein-1 in human monocytes. Thromb Haemost. 2002;88:267–273.